// company-profile
Benitec Biopharma Inc.
BNTC// activity-summary
Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by Friedman David Matthew.
// 90-day insight
Over the last 90 days, Benitec Biopharma Inc. insiders bought $0 across 1 transaction with no open-market sales.
- Most active insider: Friedman David Matthew with 1 transaction totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Benitec Biopharma Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 26, 2026 | Friedman David Matthew | BNTC | Award | 35,000 | $0.00 | $0K |
| Jan 22, 2026 | Mates Sharon | BNTC | Award | 31,500 | $0.00 | $0K |
| Dec 29, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | BNTC | Purchase | 11,587 | $13.44 | $156K |
| Dec 29, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | BNTC | Purchase | 65,800 | $13.44 | $884K |
| Dec 26, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | BNTC | Purchase | 14,320 | $13.10 | $188K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.